Our Kaplan-Meier analyses also showed that BRD4 expression was significantly correlated with overall survival, whereas BRD2 and BRD3 expression were showed no correlation based on the TCGA ccRCC cohort. This evidence concerns the gene BRD3 and nonpapillary renal cell carcinoma.